2023-05-09 17:35:54 ET
- ADMA Biologics ( NASDAQ: ADMA ) is scheduled to announce Q1 earnings results on Wednesday, May 10th, after market close.
- The consensus EPS Estimate is -$0.04 and the consensus Revenue Estimate is $53.41M (+83.5% Y/Y).
- Over the last 1 year, ADMA has beaten EPS estimates 75% of the time and has beaten revenue estimates 100% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 0 downward. Revenue estimates have seen 4 upward revisions and 0 downward.
For further details see:
ADMA Biologics Q1 2023 Earnings Preview